HOME >> MEDICINE >> NEWS
Interventional procedures significantly improve quality of life for obese patients

surgery for a BMI greater than 55 in one institution, greater than 70 in the other; cardiac disease; and sleep apnea requiring c-pap (continuous positive airway pressure, one of the most common treatments for severe apnea). Twenty patients selected for the outpatient surgery were diagnosed with post-procedure obstruction of the gastric pouch. All of these patients were admitted to the hospital for IV fluids, and stayed for three to five days until they were able to take liquids. No patient who was discharged the day of surgery was subsequently readmitted in the immediate post-operative period. Length of stay following surgery averaged four hours.

"We feel that for certain patients who can benefit from gastric banding procedures, offering an outpatient option provides them with a safe, effective alternative," said Scott Helton M.D. "Outpatient procedures are less expensive and more efficient for both the patient and the hospital. In addition, this study demonstrates that these patients can be safely operated upon in a surgicenter which further reduces the cost of the procedure."

Laparoscopic Gastric Bypass Results in Decreased Medication Costs Within Six Months (Abstract 100861*)
Undergoing gastric bypass surgery to treat morbid obesity significantly reduces medication costs for related conditions, according to research conducted by scientists at the University of Wisconsin.

The study analyzed the monthly prescription medication costs for 50 laparoscopic gastric bypass patients prior to surgery and six months post-operatively. Patients were on an average of 3.7 prescription medicines pre-op (an average cost of approximately $217.60), compared to 1.7 medications post-op (an average cost of approximately $97.30).

The results were particularly notable in patients suffering from gastroesophageal reflux disease (GERD), diabetes and hyperlipidemia, an elevation of fats such as cholesterol and triglycerides in the b
'"/>


16-May-2004


Page: 1 2 3 4 5

Related medicine news :

1. Interventional methods may increase the use of evidence-based practice
2. 9.2 million cosmetic plastic surgery procedures in 2004 - up 5%
3. Half-million cosmetic plastic surgery procedures for Hispanics in 2004 - up 49% from 2000
4. Massive weight loss patients create mass appeal for body contouring procedures
5. Drug therapy may be comparable to invasive cardiac procedures for elderly patients with heart attack
6. Invasive procedures do not necessarily improve survival for heart patients
7. Study questions safety of heart procedures at hospitals without cardiac surgery programs
8. Regionalizing some surgical procedures would not result in unreasonable travel burdens on patients
9. Smokers may want to kick butt before dental procedures
10. Few women regret sterilization procedures
11. Use of invasive heart procedures decreases after the age of 75

Post Your Comments:
(Date:10/22/2014)... October 22, 2014 Lintelus, Inc., an ... Vice President of Sales, will be speaking on the ... Technology Expo on October 28, at the Holiday Inn ... a booth as well as a Tech Demo at ... can create a more engaging event experience. , The ...
(Date:10/22/2014)... October 22, 2014 Akeso Biomedical, ... for the treatment of bacterial infections, microbial biofilms, and ... joined its board of directors. , Dr. ... Systems at The Massachusetts Institute of Technology, or MIT. ... since 1968. Dr. Sinskey also holds positions as Co-Director ...
(Date:10/22/2014)... Maureen Salamon HealthDay Reporter ... undergoing in vitro fertilization (IVF) are only about half as ... assisted reproduction technique, new research indicates, and the racial disparity ... study, about 31 percent of white patients became pregnant after ... Analyzing more than 4,000 IVF cycles over two years to ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, 2014 (HealthDay ... to increased blood pressure, according to a new study. ... pressure for young adult women or for teenagers, according to ... or moderately, their risk of high blood pressure was cut ... in older adult men and women," said lead researcher Dr. ...
(Date:10/22/2014)... Measures taken by Firestone officials at the company,s ... the spread of the disease there and could prove ... Co. provides health services to about 80,000 employees, retirees, ... Between Aug. 1 and Sept. 23, there were ... people. That incidence rate of 0.09 percent was much ...
Breaking Medicine News(10 mins):Health News:Jay Cormier, Sr. Vice President of Sales for Lintelus, Speaks about Event Technology Integration at Meetings Technology Expo in NYC 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 4Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2
(Date:10/22/2014)... JOLLA, Calif. , Oct. 22, 2014 ... RGLS ), a biopharmaceutical company leading the ... microRNAs, today announced that it has demonstrated ... an ongoing clinical study evaluating RG-101, a ... the treatment of hepatitis C virus infection ...
(Date:10/20/2014)... , 20 de octubre de 2014  PneumRx, ... campo de la pulmonología intervencional, anunció hoy la ... casi 3 meses antes de lo programado. El Estudio ... de dispositivo de investigación (IDE) aprobada por la ... sistema de espiral de reducción de volumen pulmonar ...
(Date:10/20/2014)... 20, 2014  ResMed (NYSE: RMD ... Data Exchange program, a comprehensive suite of software ... and other health care providers. ... critical patient information. It integrates valuable sleep and ... patient management platforms with customers, in-house or third-party ...
Breaking Medicine Technology:A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 3A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 5A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 6A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 7A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 8PneumRx concluye inscripción en prueba fundamental RENEW 2PneumRx concluye inscripción en prueba fundamental RENEW 3ResMed Launches ResMed Data Exchange 2
Cached News: